Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · June 14, 2023

Sacubitril/Valsartan in Heart Failure With Mildly Reduced or Preserved Ejection Fraction

European Heart Journal


Additional Info

European Heart Journal
Sacubitril/valsartan in heart failure with mildly reduced or preserved ejection fraction: a pre-specified participant-level pooled analysis of PARAGLIDE-HF and PARAGON-HF
Eur Heart J 2023 May 21;[EPub Ahead of Print], M Vaduganathan, RJ Mentz, BL Claggett, ZM Miao, IJ Kulac, JH Ward, AF Hernandez, DA Morrow, RC Starling, EJ Velazquez, KM Williamson, AS Desai, S Zieroth, M Lefkowitz, JJV McMurray, E Braunwald, SD Solomon

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading